CIT-110
/ Cureimmune Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 29, 2025
Activity of LpxC inhibitors on carbapenemase producing Citrobacter spp. clinical isolates.
(PubMed, J Glob Antimicrob Resist)
- "strains, with low (Cit 52) and high (Cit 110) LpxC inhibitor MIC values...Although LpxC-4 had a lower MIC90 value compared to CHIR-090, CHIR-090 showed a bactericidal effect at short times and prevented the regrowth of both isolates in time-kill assays. In terms of cross resistance, all three structurally similar LpxC inhibitors showed a moderate positive correlation between their activity."
Journal • Infectious Disease
1 to 1
Of
1
Go to page
1